WS
XTNT icon

Wedbush Securities’s Xtant Medical Holdings XTNT Stock Holding History

Wedbush Securities’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-89,566
Closed -$74K – 983
2020
Q3 		$74K Buy
89,566
+20,307
+29% +$19.9K 0.01% 853
2020
Q2 		$62K Buy
+69,259
New +$63.5K 0.01% 893

Other funds holding XTNT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Wedbush Securities's XTNT Position: Q4 2020 in Review

Wedbush Securities sold out of Xtant Medical Holdings (XTNT) in Q4 2020, closing a stake of 89,566 shares — an estimated $74K sold.

Wedbush Securities first reported a position in XTNT in Q2 2020 and held it in 2 quarters. The position peaked at $74K in Q3 2020. 20 funds tracked by Wall St. Rank hold XTNT as of Q4 2020.

  • Wedbush Securities reported no remaining Xtant Medical Holdings position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 89,566 Xtant Medical Holdings shares in Q4 2020, an estimated $74K.
  • Wedbush Securities first reported a position in Xtant Medical Holdings in Q2 2020 and held it in 2 quarters.
  • Wedbush Securities's Xtant Medical Holdings position peaked at $74K in Q3 2020.
  • 20 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.